The native bacterial and viral antigens market is expected to reach US$ 28,801.15 thousand by 2027 from US$ 17,105.05 thousand in 2019; it is estimated to grow at a CAGR of 6.8% from 2020 to 2027.
Native antigens are extracted in their natural form from the respective sources. As they undergo usual modifications in vivo, upon isolation, they exhibit close resemblance withthe complex 3-dimensional structure they exhibit in the host. In the case of protein antigens, these modifications may include post-translational alterations such as cleavage of precursor proteins, formation of disulphide bonds, and addition of low molecular weight groups through processes such as glycosylation or phosphorylation. The global native bacterial and viral antigens market is driven by factors such as increasing use of native microbial antigens in diagnostics and therapeutics, and rising prevalence of infectious diseases. However, the limitations associated with native antigens such as high cost, low antigen production levels, and scale-up difficultieshinder the market growth.However, emerging markets are creating growth opportunities for the market players.
Lucrative Regional Markets for Native Bacterial and Viral Antigens
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Use of Native Microbial Antigens in Diagnostics and Therapeutics
Antigens are the biomolecules that are capable of triggering immune response in host body through the activation of lymphocytes. Bacterial antigens are used in the development of various types of antibodies in research laboratories for the improvement of immune systems. Moreover, bacterial antigens are also widely used in immunodiagnostic assays such as ELISA.
Panning of native antigen libraries have led to development of potent neutralization antibodies against various bacterial and viral infections. The native antigens are extracted in their natural form from a corresponding source. There is high demand for a large number of native antigens, especially in in vitro diagnostics and vaccine research. According to various scientific studies, recombinant antigens exhibit solubility and aggregation issues. Further, the association of recombinant antigens with non-protein entities is also different and sometimes lacking in terms of performance as compared to native antigens.
With the recent outbreak of COVID-19, companies are developing commercial SARS-CoV-2 antigens to support the vaccine formulation, and research and development to strengthen the disease diagnosis and therapy. In February 2020, the Native Antigen Company became the first company to commercially provide the novel coronavirus antigens, using the company’s proprietary VirtuE (HEK293) expression system. Thus, the rising use of native antigens, effectively supporting the diagnostics and therapeutics of various medical conditions, boosts the growth of the native bacterial antigen and antibody market.
Product Type-Based Insights
The native bacterial and viral antigens market,based on product type, is segmented into chlamydia antigens, adenovirus antigens, borrelia antigens, clostridium antigens, chikungunya virus antigens, and dengue virus antigens. The chlamydia antigens segment held the largest share of the market in 2019, and the market for the same is anticipated to grow at the highest CAGR during the forecast period. Growth of the market for this segment is attributed to easy availability of these antigens, with majority of the market players commercially offering these antigens in the native forms. Further, the use of chlamydiaantigens in research institutes and laboratories for the development of vaccines and in vitro diagnostics (IVD) tests is further expected to propel the growth of the market for this segment.
Native Bacterial and Viral Antigens Market, by Technology– 2018 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Pathogen Type-Based Insights
Based on pathogen type, the native bacterial and viral antigens market is segmented into inactivated pathogen and purified pathogen. The inactivated pathogen segment held a larger share of the market in 2019, and it is estimated to register a higher CAGR during the forecast period.
Application-Based Insights
Based on application, the native bacterial and viral antigens market is segmented into ELISA, immunoassay, SDS-PAGE, hemagglutination, and agglutination tests. The ELISA segment held the largest share of the market in 2019 and is estimated to register the highest CAGR during 2020–2027.
End User-Based Insights
Based on end user, the native bacterial and viral antigens market is segmented into diagnostic laboratories and centers and academic and research institutes. The diagnostic laboratories and centers segment held the largest share of the market in 2019, and it is estimated to register the highest CAGR from 2020 to 2027.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Native Bacterial and Viral Antigens Market: Strategic Insights
Market Size Value in US$ 17,105.05 thousand in 2019 Market Size Value by US$ 28,801.15 thousand by 2027 Growth rate CAGR of 6.8% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Native Bacterial and Viral Antigens Market: Strategic Insights
| Market Size Value in | US$ 17,105.05 thousand in 2019 |
| Market Size Value by | US$ 28,801.15 thousand by 2027 |
| Growth rate | CAGR of 6.8% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Product launches and approvalsare the commonly adopted strategies by companies to expand their global footprintsand product portfolios; these strategies help them meet the growing consumer demand. Collaboration is one of the major strategies adopted by the companies operating in the native bacterial and viral antigens market to enlarge customer base worldwide, which also permits them to maintain their brand name globally.
Native Bacterial and Viral Antigens Market – byProduct Type
- Chlamydia Antigens
- Adenovirus Antigens
- Borrelia Antigens
- Chikungunya Virus Antigens
- Clostridium Antigens
- Dengue Virus Antigens
Native Bacterial and Viral Antigens Market – by Pathogen Type
- Inactivated Pathogen
- Purified Pathogen
Native Bacterial and Viral Antigens Market – by Application
- ELISA
- Immunoassay
- SDS-PAGE
- Hemagglutination
- Agglutination Test
Native Bacterial and Viral Antigens Market – by EndUser
- Diagnostic Laboratories and Centers
- Academic and Research Institutes
Native Bacterial and Viral Antigens Market– by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
South and Central America
- Brazil
- Argentina
- Rest of South America
Company Profiles
- BIO-RAD LABORATORIES INC.
- Microbix Biosystems
- SERION Immunologics
- Aalto Bio Reagents Ltd
- Enzo Life Sciences Inc.
- Jena Bioscience GmbH
- ROSS SOUTHERN LABORATORIES
- The Native Antigen Company
- Creative Diagnostics
- TRINA BIOREACTIVES AG
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product Type , Pathogen Type ; Application , End User , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Native antigens are extracted in their natural form from an appropriate source. Because they have undergone the usual modifications that would occur in vivo, they bear a very close resemblance when isolated to the complex 3-dimensional structure they exhibit in the host. In the case of protein antigens, these modifications can include post-translational alterations such as cleavage of precursor proteins, formation of disulphide bonds, and addition of low molecular weight groups through processes such as glycosylation or phosphorylation.
Factors such as increasing use of native microbial antigens in diagnostics and therapeutics, and rising prevalence of infectious diseases drive the growth of the market.Moreover, developments in emerging markets is expected to offer lucrative opportunities for the growth of the market.
The native bacterial and viral antigensmarket majorly consists of the players such as BIO-RAD LABORATORIES, INC., Microbix Biosystems, SERION Immunologics, Aalto Bio Reagents Ltd., Enzo Life Sciences, Inc., Jena Bioscience GmbH, ROSS SOUTHERN LABORATORIES, The Native Antigen Company, Creative Diagnostics, and TRINA BIOREACTIVES AG amongst others.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Native Bacterial and Viral Antigens Market – By Product Type
1.3.2 Global Native Bacterial and Viral Antigens Market – By Pathogen Type
1.3.3 Global Native Bacterial and Viral Antigens Market – By Application
1.3.4 Global Native Bacterial and Viral Antigens Market – By End User
1.3.5 Global Native Bacterial and Viral Antigens Market – By Geography
2. Native Bacterial and Viral Antigens Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Native Bacterial and Viral Antigens Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Expert Opinions
5. Native Bacterial and Viral Antigens Market– Key Market Dynamics
5.1.1 Increasing Use of Native Microbial Antigens in Diagnostics and Therapeutics
5.1.2 Rising Prevalence of Infectious Diseases
5.2 Market Restraints
5.2.1 Limitations Associated with Native Antigens such as High Cost, Low Antigen Production Levels, Scale-up Difficulties
5.3 Market Opportunities
5.3.1 Developments in Emerging Economies
5.4 Future Trend
5.4.1 Growing Focus on Immunization Programs
5.5 Impact Analysis
6. Native Bacterial and Viral Antigens Market – Global Analysis
6.1 Global Native Bacterial and Viral Antigens Market Revenue Forecast and Analysis
6.2 Global Native Bacterial and Viral Antigens Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Native Bacterial and Viral Antigens Market Analysis – By Product Type
7.1 Overview
7.2 Native Bacterial and Viral Antigens Market Revenue Share, by Product Type (2019 and 2027)
7.3 Chlamydia Antigens
7.3.1 Overview
7.3.2 Chlamydia Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
7.4 Adenovirus Antigens
7.4.1 Overview
7.4.2 Adenovirus Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
7.5 Borrelia Antigens
7.5.1 Overview
7.5.2 Borrelia Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
7.6 Chikungunya Virus Antigens
7.6.1 Overview
7.6.2 Chikungunya Virus Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
7.7 Clostridium Antigens
7.7.1 Overview
7.7.2 Clostridium Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
7.8 Dengue Virus Antigens
7.8.1 Overview
7.8.2 Dengue Virus Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
8. Native Bacterial and Viral Antigens Market Analysis – By Pathogen Type
8.1 Overview
8.2 Native Bacterial and Viral Antigens Market Revenue Share, by Pathogen Type (2019 and 2027)
8.3 Inactivated Pathogen
8.3.1 Overview
8.3.2 Inactivated Pathogen: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
8.4 Purified Pathogen
8.4.1 Overview
8.4.2 Purified Pathogen: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
9. Native Bacterial and Viral Antigens Market Analysis – By Application
9.1 Overview
9.2 Native Bacterial and Viral Antigens Market Revenue Share, by Application (2019 and 2027)
9.3 ELISA
9.3.1 Overview
9.3.2 ELISA: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
9.4 Immunoassay
9.4.1 Overview
9.4.2 Immunoassay: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
9.5 SDS-PAGE
9.5.1 Overview
9.5.2 SDS-PAGE: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
9.6 Hemagglutination
9.6.1 Overview
9.6.2 Hemagglutination: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
9.7 Agglutination Test
9.7.1 Overview
9.7.2 Agglutination Test: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
10. Native Bacterial and Viral Antigens Market Analysis – By End User
10.1 Overview
10.2 Native Bacterial and Viral Antigens Market Revenue Share, by End User (2019 and 2027)
10.3 Diagnostic Laboratories and Centers
10.3.1 Overview
10.3.2 Diagnostic Laboratories and Centers: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
10.4 Academic and Research Institutes
10.4.1 Overview
10.4.2 Academic and Research Institutes: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
11. Native Bacterial and Viral Antigens Market Analysis and Forecasts To 2027 Geographical Analysis
11.1 North America: Native Bacterial and Viral Antigens Market
11.1.1 Overview
11.1.2 North America: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (USD Thousand)
11.1.3 North America: Native Bacterial and Viral Antigens Market, by Product Type, 2018–2027 (USD Thousand)
11.1.4 North America: Native Bacterial and Viral Antigens Market, by Pathogen Type, 2018–2027 (USD Thousand)
11.1.5 North America: Native Bacterial and Viral Antigens Market, By Application, 2018–2027 (USD Thousand)
11.1.6 North America: Native Bacterial and Viral Antigens Market, By End User, 2018–2027 (USD Thousand)
11.1.7 North America: Native Bacterial and Viral Antigens Market, by Country, 2019 & 2027 (%)
11.1.8 US: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (USD Thousand)
11.1.8.1 US: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (USD Thousand)
11.1.8.2 US: Native Bacterial and Viral Antigens Market, by Product Type, 2018–2027 (USD Thousand)
11.1.8.3 US: Native Bacterial and Viral Antigens Market, By Pathogen Type, 2018–2027 (USD Thousand)
11.1.8.4 US: Native Bacterial and Viral Antigens Market, By Application, 2018–2027 (USD Thousand)
11.1.8.5 US: Native Bacterial and Viral Antigens Market, By End User, 2018–2027 (USD Thousand)
11.1.9 Canada: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (USD Thousand)
11.1.9.1 Canada: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (USD Thousand)
11.1.9.2 Canada: Native Bacterial and Viral Antigens Market, By Product Type, 2018–2027 (USD Thousand)
11.1.9.3 Canada: Native Bacterial and Viral Antigens Market, By Pathogen Type, 2018–2027 (USD Thousand)
11.1.9.4 Canada: Native Bacterial and Viral Antigens Market, By Application, 2018–2027 (USD Thousand)
11.1.9.5 Canada: Native Bacterial and Viral Antigens Market, By End User, 2018–2027 (USD Thousand)
11.1.10 Mexico: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (USD Thousand)
11.1.10.1 Mexico: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (USD Thousand)
11.1.10.2 Mexico: Native Bacterial and Viral Antigens Market, By Product Type, 2018–2027 (USD Thousand)
11.1.10.3 Mexico: Native Bacterial and Viral Antigens Market, By Pathogen Type, 2018–2027 (USD Thousand)
11.1.10.4 Mexico: Native Bacterial and Viral Antigens Market, By Application, 2018–2027 (USD Thousand)
11.1.10.5 Mexico: Native Bacterial and Viral Antigens Market, By End User, 2018–2027 (USD Thousand)
11.2 Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts To 2027
11.2.1 Europe Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.2 Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.2.3 Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.2.4 Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.2.5 Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.2.6 Europe Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027, By Country (%)
11.2.7 UK Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.7.1 UK Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.7.2 UK Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.2.7.3 UK Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.2.7.4 UK Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.2.7.5 UK Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.2.8 Germany Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.8.1 Germany Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.8.2 Germany Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.2.8.3 Germany Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.2.8.4 Germany Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.2.8.5 Germany Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.2.9 France Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.9.1 France Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.9.2 France Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.2.9.3 France Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.2.9.4 France Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.2.9.5 France Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.2.10 Italy Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.10.1 Italy Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.10.2 Italy Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.2.10.3 Italy Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.2.10.4 Italy Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.2.10.5 Italy Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.2.11 Spain Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.11.1 Spain Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.11.2 Spain Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.2.11.3 Spain Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.2.11.4 Spain Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.2.11.5 Spain Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.3 Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts To 2027
11.4 Asia Pacific Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.1 Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.4.2 Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.4.3 Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.4.4 Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.4.5 Asia Pacific Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027, By Country (%)
11.4.6 Japan Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.6.1 Japan Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.6.2 Japan Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.4.6.3 Japan Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.4.6.4 Japan Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.4.6.5 Japan Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.4.7 China Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.7.1 China Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.7.2 China Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.4.7.3 China Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.4.7.4 China Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.4.7.5 China Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.4.8 India Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.8.1 India Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.8.2 India Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.4.8.3 India Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.4.8.4 India Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.4.8.5 India Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.4.9 South Korea Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.9.1 South Korea Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.9.2 South Korea Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.4.9.3 South Korea Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.4.9.4 South Korea Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.4.9.5 South Korea Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.4.10 Australia Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.10.1 Australia Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.10.2 Australia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.4.10.3 Australia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.4.10.4 Australia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.4.10.5 Australia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.5 Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts To 2027
11.5.1 Middle East & Africa Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.5.2 Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.5.3 Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.5.4 Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.5.5 Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.5.6 Middle East & Africa Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027, By Country (%)
11.5.7 UAE Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.5.7.1 UAE Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.5.7.2 UAE Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.5.7.3 UAE Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.5.7.4 UAE Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.5.7.5 UAE Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.5.8 Saudi Arabia Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.5.8.1 Saudi Arabia Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.5.8.2 Saudi Arabia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.5.8.3 Saudi Arabia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.5.8.4 Saudi Arabia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.5.8.5 Saudi Arabia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.5.9 South Africa Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.5.9.1 South Africa Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.5.9.2 South Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.5.9.3 South Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.5.9.4 South Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.5.9.5 South Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.6 South And Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts To 2027
11.6.1 South and Central America Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.6.2 South and Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.6.3 South and Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.6.4 South and Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.6.5 South and Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.6.6 South and Central America Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027, By Country (%)
11.6.7 Argentina Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.6.7.1 Argentina Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.6.7.2 Argentina Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.6.7.3 Argentina Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.6.7.4 Argentina Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.6.7.5 Argentina Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.6.8 Brazil Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.6.8.1 Brazil Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.6.8.2 Brazil Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.6.8.3 Brazil Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.6.8.4 Brazil Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.6.8.5 Brazil Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
12. Impact of COVID-19 Pandemic on Global Anti-Viral Therapies Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Rest of World: Impact Assessment of COVID-19 Pandemic
13. Native Bacterial and Viral Antigens Market – Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 BIO-RAD LABORATORIES INC.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Microbix Biosystems
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 SERION Immunologics
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Aalto Bio Reagents Ltd
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Enzo Life Sciences, Inc.,
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Jena Bioscience GmbH
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 ROSS SOUTHERN LABORATORIES
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 The Native Antigen Company
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Creative Diagnostics
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 TRINA BIOREACTIVES AG
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Native Bacterial and Viral Antigens Market, by Product Type– Revenue and Forecast to 2027 (USD Thousand)
Table 2. North America Native Bacterial and Viral Antigens Market, by Pathogen Type – Revenue and Forecast to 2027 (USD Thousand)
Table 3. North America Native Bacterial and Viral Antigens Market, By Application – Revenue and Forecast to 2027 (USD Thousand)
Table 4. North America Native Bacterial and Viral Antigens Market, By End User – Revenue and Forecast to 2027 (USD Thousand)
Table 5. US Native Bacterial and Viral Antigens Market, by Product Type – Revenue and Forecast to 2027 (USD Thousand)
Table 6. US Native Bacterial and Viral Antigens Market, By Pathogen Type – Revenue and Forecast to 2027 (USD Thousand)
Table 7. US Native Bacterial and Viral Antigens Market, By Application – Revenue and Forecast to 2027 (USD Thousand)
Table 8. US Native Bacterial and Viral Antigens Market, By End User – Revenue and Forecast to 2027 (USD Thousand)
Table 9. Canada Native Bacterial and Viral Antigens Market, By Product Type – Revenue and Forecast to 2027 (USD Thousand)
Table 10. Canada Native Bacterial and Viral Antigens Market, By Pathogen Type – Revenue and Forecast to 2027 (USD Thousand)
Table 11. Canada Native Bacterial and Viral Antigens Market, By Application – Revenue and Forecast to 2027 (USD Thousand)
Table 12. Canada Native Bacterial and Viral Antigens Market, By End User – Revenue and Forecast to 2027 (USD Thousand)
Table 13. Mexico Native Bacterial and Viral Antigens Market, By Product Type – Revenue and Forecast to 2027 (USD Thousand)
Table 14. Mexico Native Bacterial and Viral Antigens Market, By Pathogen Type – Revenue and Forecast to 2027 (USD Thousand)
Table 15. Mexico Native Bacterial and Viral Antigens Market, By Application – Revenue and Forecast to 2027 (USD Thousand)
Table 16. Mexico Native Bacterial and Viral Antigens Market, By End User – Revenue and Forecast to 2027 (USD Thousand)
Table 17. Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
Table 18. Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
Table 19. Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
Table 20. Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
Table 21. UK Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
Table 22. UK Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
Table 23. UK Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
Table 24. UK Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
Table 25. Germany Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
Table 26. Germany Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
Table 27. Germany Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
Table 28. Germany Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
Table 29. France Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
Table 30. France Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
Table 31. France Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
Table 32. France Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
Table 33. Italy Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
Table 34. Italy Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
Table 35. Italy Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
Table 36. Italy Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
Table 37. Spain Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
Table 38. Spain Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
Table 39. Spain Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
Table 40. Spain Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
Table 41. Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
Table 42. Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
Table 43. Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
Table 44. Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
Table 45. Japan Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
Table 46. Japan Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
Table 47. Japan Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
Table 48. Japan Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
Table 49. China Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
Table 50. China Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
Table 51. China Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
Table 52. China Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
Table 53. India Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
Table 54. India Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
Table 55. India Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
Table 56. India Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
Table 57. South Korea Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
Table 58. South Korea Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
Table 59. South Korea Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
Table 60. South Korea Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
Table 61. Australia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
Table 62. Australia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
Table 63. Australia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
Table 64. Australia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
Table 65. Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
Table 66. Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
Table 67. Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
Table 68. Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
Table 69. UAE Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
Table 70. UAE Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
Table 71. UAE Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
Table 72. UAE Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
Table 73. Saudi Arabia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
Table 74. Saudi Arabia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
Table 75. Saudi Arabia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
Table 76. Saudi Arabia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
Table 77. South Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
Table 78. South Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
Table 79. South Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
Table 80. South Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
Table 81. South and Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
Table 82. South and Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
Table 83. South and Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
Table 84. South and Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
Table 85. Argentina Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
Table 86. Argentina Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
Table 87. Argentina Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
Table 88. Argentina Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
Table 89. Brazil Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
Table 90. Brazil Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
Table 91. Brazil Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
Table 92. Brazil Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
Table 93. Organic Developments Done By Companies
Table 94. Inorganic Developments Done by Companies
Table 95. Glossary of Terms, Native Bacterial and Viral Antigens Market
LIST OF FIGURES
Figure 1. Native Bacterial and Viral Antigens Market Segmentation
Figure 2. Native Bacterial and Viral Antigens Market Segmentation, By Region
Figure 3. Native Bacterial and Viral Antigens Market Overview
Figure 4. Chlamydia Antigens Segment Held Largest Share of Native Bacterial and Viral Antigens Market
Figure 5. Europe to Show Significant Growth During Forecast Period
Figure 6. Native Bacterial and Viral Antigens Market, by Geography (US$ Thousand)
Figure 7. Global Native Bacterial and Viral Antigens Market – Leading Country Markets (US$ Thousand)
Figure 8. Global Native Bacterial and Viral Antigens Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Native Bacterial and Viral Antigens Market Impact Analysis of Driver and Restraints
Figure 15. Global Native Bacterial and Viral Antigens Market – Revenue Forecast And Analysis – 2019- 2027
Figure 16. Global Native Bacterial and Viral Antigens Market – By Geography Forecast and Analysis – 2019- 2027
Figure 17. Market Positioning Of Key Players In Global Native Bacterial and Viral Antigens Market
Figure 18. Native Bacterial and Viral Antigens Market Revenue Share, by Product Type (2019 and 2027)
Figure 19. Chlamydia Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 20. Adenovirus Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 21. Borrelia Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 22. Chikungunya Virus Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 23. Clostridium Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 24. Dengue Virus Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 25. Native Bacterial and Viral Antigens Market Revenue Share, by Pathogen Type (2019 and 2027)
Figure 26. Inactivated Pathogen: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 27. Purified Pathogen: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 28. Native Bacterial and Viral Antigens Market Revenue Share, by Application (2019 and 2027)
Figure 29. ELISA: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 30. Immunoassay: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 31. SDS-PAGE: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 32. Hemagglutination: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 33. Agglutination Test: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 34. Native Bacterial and Viral Antigens Market Revenue Share, by End User (2019 and 2027)
Figure 35. Diagnostic Laboratories and Centers: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 36. Academic and Research Institutes: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 37. North America: Native Bacterial and Viral Antigens Market, by Key Country – Revenue (2019) (USD Thousand)
Figure 38. North America Native Bacterial and Viral Antigens Market Revenue and Forecast to 2027 (USD Thousand)
Figure 39. North America: Native Bacterial and Viral Antigens Market, by Country, 2019 & 2027 (%)
Figure 40. US: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 41. Canada: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 42. Mexico: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 43. Europe Native Bacterial and Viral Antigens Market Overview, by Country (2018)
Figure 44. Europe Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
Figure 45. Europe Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027, By Country (%)
Figure 46. UK Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
Figure 47. Germany Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
Figure 48. France Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
Figure 49. Italy Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
Figure 50. Spain Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
Figure 51. Asia Pacific Native Bacterial and Viral Antigens Market Overview, by Country (2018)
Figure 52. Asia Pacific Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
Figure 53. Asia Pacific Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027, By Country (%)
Figure 54. Japan Market Revenue and Forecasts to 2027 (US$ Thousand)
Figure 55. China Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
Figure 56. India Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
Figure 57. South Korea Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
Figure 58. Australia Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
Figure 59. Middle East & Africa Native Bacterial and Viral Antigens Market Revenue Overview, by Country, 2018 (US$ Thousand)
Figure 60. Middle East & Africa Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
Figure 61. Middle East & Africa Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027, By Country (%)
Figure 62. UAE Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
Figure 63. Saudi Arabia Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
Figure 64. South Africa Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
Figure 65. South and Central America Native Bacterial and Viral Antigens Market Revenue Overview, by Country, 2018 (US$ Thousand)
Figure 66. South and Central America Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
Figure 67. South and Central America Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027, By Country (%)
Figure 68. Argentina Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
Figure 69. Brazil Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
Figure 70. Impact of COVID-19 Pandemic in North American Country Markets
Figure 71. Impact of COVID-19 Pandemic in Europe Country Markets
Figure 72. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
Figure 73. Impact of COVID-19 Pandemic in Rest of World Country Markets
Figure 74. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Native Bacterial and Viral Antigens Market
- BIO-RAD LABORATORIES INC.
- Microbix Biosystems
- SERION Immunologics
- Aalto Bio Reagents Ltd
- Enzo Life Sciences Inc.
- Jena Bioscience GmbH
- ROSS SOUTHERN LABORATORIES
- The Native Antigen Company
- Creative Diagnostics
- TRINA BIOREACTIVES AG
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Native Bacterial and Viral Antigens Market
Sep 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Sep 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Sep 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Sep 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Sep 2020